Antitumor Effect of GnRH Agonist in Epithelial Ovarian Cancer

Author： Kim J.H.   Park D.C.   Kim J.W.   Choi Y.K.   Lew Y.O.   Kim D.H.   Jung J.K.   Lim Y.A.   Namkoong S.E.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.74, Iss.2, 1999-08, pp. : 170-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GnRH Agonists and Antagonists in Cancer Therapy

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 6, 2003-11 ,pp. : 399-410

Bentham Science Publishers

Access to resources Recommend Favorite

Oxime bond-linked daunorubicin-GnRH-III bioconjugates exert antitumor activity in castration-resistant prostate cancer cells via the type I GnRH receptor

By  

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 243-253

Spandidos Publications

Access to resources Recommend Favorite

Protection of ovarian function by GnRH agonists during chemotherapy: A meta-analysis

By        

International Journal of Oncology, Vol. 44, Iss. 4, 2014-01 ,pp. : 1335-1340

Spandidos Publications

Access to resources Recommend Favorite

GnRH analogs reduce invasiveness of human breast cancer cells

By Alten Julia   Fister Stefanie   Schulz Hiltrud   Viereck Volker   Frosch Karl-Heinz   Emons Günter   Gründker Carsten  

Breast Cancer Research and Treatment, Vol. 100, Iss. 1, 2006-11 ,pp. : 13-21

Springer Publishing Company

Access to resources Recommend Favorite

Late Intracaval and Intracardiac Leiomyomatosis Following Hysterectomy for Benign Myomas Treated by Surgery and GnRH Agonist

By Morice P.   Chapelier A.   Dartevelle P.   Castaigne D.   Lhomme C.  

Gynecologic Oncology, Vol. 83, Iss. 2, 2001-11 ,pp. : 422-423

Elsevier

Access to resources Recommend Favorite